Therapeutic drug monitoring in patients with inflammatory bowel disease on ustekinumab.

Adam SalehRachel StadingNatalia MiroballiKerri GlassnerBincy P Abraham

Published in: Journal of digestive diseases (2024)

Higher UST levels correlated with less disease activity. BMI was an important consideration for UST response as well. Therefore, UST dose adjustments to reach target levels may optimize response.

Keyphrases

disease activity
patients with inflammatory bowel disease
systemic lupus erythematosus
rheumatoid arthritis
rheumatoid arthritis patients
ankylosing spondylitis
body mass index
juvenile idiopathic arthritis
weight gain
weight loss